• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma.

作者信息

Monson J M, Stark P, Reilly J J, Sugarbaker D J, Strauss G M, Swanson S J, Decamp M M, Mentzer S J, Baldini E H

机构信息

Joint Center for Radiation Therapy, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Cancer. 1998 Mar 1;82(5):842-50.

PMID:9486572
Abstract

BACKGROUND

The authors attempted to determine the incidence of and risk factors for clinical radiation pneumonitis in patients treated for lung carcinoma. They also sought to describe the corresponding posttreatment radiographic changes.

METHODS

Between 1989-1993, 83 patients received curative radiation therapy for lung carcinoma. Of these, 39 patients were treated with definitive radiation therapy, and 44 patients were treated with adjuvant radiation therapy after surgical resection. The median radiation therapy dose was 54 gray (Gy), and the median treatment area was 182 cm2. Chest radiographs obtained after radiation therapy were reviewed and scored for margin definition, volume loss, and texture quality.

RESULTS

A total of 17 patients (20%) developed clinical radiation pneumonitis (CRP). The median radiation therapy dose for the CRP cohort was 54 Gy, and the median treatment volume was 193 cm2. The median time to onset of symptoms was 3 weeks after radiation therapy, and the median duration of symptoms was 10 weeks. Of the 15 evaluable patients, symptoms resolved for 9 patients, improved but persisted for 4 patients, and CRP was fatal for 2 patients. The incidence of CRP was increased for patients with low performance status, comorbid lung disease, smoking history, low pulmonary function tests, and for those patients who did not undergo a surgical resection. Posttreatment radiographic changes were common and progressed with time. Radiographic changes were more pronounced in the CRP cohort, and extended outside the radiation therapy treatment field in the majority of patients (67%).

CONCLUSIONS

Clinical radiation pneumonitis developed in 20% of lung carcinoma patients. Risk factors included low performance status, comorbid lung disease, smoking history, low pulmonary function tests, and the absence of a surgical resection. Posttreatment radiograph changes were common and progressed with time, and typically were not confined to the radiation therapy treatment field.

摘要

相似文献

1
Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma.
Cancer. 1998 Mar 1;82(5):842-50.
2
A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.非小细胞肺癌适形放疗后放射性肺炎的前瞻性研究:临床与剂量学因素分析
Radiother Oncol. 2004 May;71(2):175-81. doi: 10.1016/j.radonc.2004.02.005.
3
A prospective study of whether radiation pneumonitis is influenced by low-dose irradiated lung volume in primary lung cancer with chronic pulmonary disease.一项关于慢性肺部疾病的原发性肺癌中,放射性肺炎是否受低剂量照射肺体积影响的前瞻性研究。
Gan To Kagaku Ryoho. 2007 Feb;34(2):213-6.
4
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.与间皮瘤调强放射治疗相关的致命性肺炎
Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):640-5. doi: 10.1016/j.ijrobp.2006.03.012.
5
Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.血清标志物能否用于预测肺癌患者的急性和晚期毒性?RTOG 91-03分析。
Am J Clin Oncol. 2007 Aug;30(4):368-76. doi: 10.1097/01.coc.0000260950.44761.74.
6
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.术前超分割放化疗用于既往盆腔放疗后的局部复发性直肠癌患者:一项多中心II期研究。
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. doi: 10.1016/j.ijrobp.2005.09.017. Epub 2006 Jan 18.
7
Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.血浆转化生长因子-β水平在非小细胞肺癌放射治疗中的意义
Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1378-87. doi: 10.1016/j.ijrobp.2003.09.078.
8
Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy.接受大分割放射治疗的恶性肺部病变患者的放射性肺炎
Radiother Oncol. 2009 Jun;91(3):307-13. doi: 10.1016/j.radonc.2009.02.003. Epub 2009 Mar 25.
9
Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.放射性肺炎的预测:62例非小细胞肺癌患者三维适形放疗后剂量体积直方图分析
Neoplasma. 2005;52(1):56-62.
10
Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients.肺癌患者中转化生长因子-β的血浆动力学及放疗后肺损伤
Radiother Oncol. 2004 May;71(2):183-9. doi: 10.1016/j.radonc.2004.01.019.

引用本文的文献

1
Biomarkers associated with pulmonary exacerbations in a randomized trial of nintedanib for radiation pneumonitis.与尼达尼布治疗放射性肺炎随机试验中肺恶化相关的生物标志物。
Radiother Oncol. 2024 Jul;196:110320. doi: 10.1016/j.radonc.2024.110320. Epub 2024 May 11.
2
Lung cancer, comorbidities, and medication: the infernal trio.肺癌、合并症与药物治疗:这一棘手的三重难题。
Front Pharmacol. 2024 Feb 21;14:1016976. doi: 10.3389/fphar.2023.1016976. eCollection 2023.
3
Analysis of the risk factors of radiation pneumonitis in patients after radiotherapy for esophageal squamous cell carcinoma.
食管鳞状细胞癌放疗后患者放射性肺炎的危险因素分析
Front Oncol. 2023 Nov 7;13:1198872. doi: 10.3389/fonc.2023.1198872. eCollection 2023.
4
Predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unresectable locally advanced non-small cell lung carcinoma.durvalumab 维持治疗在不可切除局部晚期非小细胞肺癌同期放化疗后肺损伤的预测因素。
Thorac Cancer. 2023 Sep;14(25):2601-2607. doi: 10.1111/1759-7714.15042. Epub 2023 Aug 2.
5
Evaluation of variables predicting PFT changes for lung cancer patients treated on a prospective 4DCT-ventilation functional avoidance clinical trial.评价变量预测前瞻性 4DCT-通气功能回避临床试验治疗的肺癌患者 PFT 变化。
Radiother Oncol. 2023 Oct;187:109821. doi: 10.1016/j.radonc.2023.109821. Epub 2023 Jul 28.
6
The effects of inspiratory muscle training with pulmonary rehabilitation on NSCLC patients during radiation therapy: A pilot clinical study.吸气肌训练联合肺康复对放疗期间非小细胞肺癌患者的影响:一项初步临床研究。
Thorac Cancer. 2023 Jun;14(17):1567-1573. doi: 10.1111/1759-7714.14899. Epub 2023 Apr 20.
7
Impact of Tobacco Smoking on Outcomes of Radiotherapy: A Narrative Review.吸烟对放疗结果的影响:一篇叙述性综述。
Curr Oncol. 2022 Mar 24;29(4):2284-2300. doi: 10.3390/curroncol29040186.
8
Exploration of radiation-induced lung injury, from mechanism to treatment: a narrative review.辐射诱导的肺损伤:从机制到治疗的探索:一篇叙述性综述
Transl Lung Cancer Res. 2022 Feb;11(2):307-322. doi: 10.21037/tlcr-22-108.
9
Radiation-Induced Lung Injury-Current Perspectives and Management.辐射诱导的肺损伤——当前观点与管理
Clin Pract. 2021 Jul 1;11(3):410-429. doi: 10.3390/clinpract11030056.
10
Investigating the SPECT Dose-Function Metrics Associated With Radiation-Induced Lung Toxicity Risk in Patients With Non-small Cell Lung Cancer Undergoing Radiation Therapy.研究接受放射治疗的非小细胞肺癌患者中与辐射诱导的肺毒性风险相关的单光子发射计算机断层扫描剂量函数指标。
Adv Radiat Oncol. 2021 Feb 7;6(3):100666. doi: 10.1016/j.adro.2021.100666. eCollection 2021 May-Jun.